Tauriga Sciences, Inc. announced the appointment of Hingge Hsu, to its Board of Directors. Dr. Hingge Hsu was recently a Partner at Fidelity Biosciences and was on the core healthcare investment team for Fidelity Growth Partners Asia. He was previously a Managing Director at Lehman Brothers in their Private Equity Group.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | 0.00% | 0.00% | 0.00% |
2022 | Tauriga Sciences Inc. Receives its 10,000th E-Commerce Order | CI |
2022 | Tauriga Sciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021 | CI |
1st Jan change | Capi. | |
---|---|---|
+38.69% | 723B | |
+34.28% | 595B | |
-4.49% | 369B | |
+20.24% | 332B | |
+2.12% | 282B | |
+17.02% | 244B | |
+9.31% | 208B | |
-5.07% | 205B | |
-0.35% | 168B |
- Stock Market
- Equities
- TAUG Stock
- News Tauriga Sciences, Inc.
- Tauriga Sciences, Inc. Appoints Hingge Hsu to its Board of Directors